The recently identified hexosaminidase D enzyme substantially contributes to the elevated hexosaminidase activity in rheumatoid arthritis

Immunology Letters

Volumn 149, Issue 1-2, 2013, Pages 71-76

  Pásztói, Mária ^a,b   Sódar, Barbara ^a   Misják, Petra ^a   Pálóczi, Krisztina ^a   Kittel, Ágnes ^b   Tóth, Kálmán ^c   Wellinger, Károly ^c   Géher, Pál ^a   Nagy, György ^a   Lakatos, Tamás ^a   Falus, András ^a,b   Buzás, Edit Irén ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Extracellular vesicle; Hexosaminidase; Rheumatoid arthritis; Synovial fibroblast; Transforming growth factor beta

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; HEXOSAMINIDASE D; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LOCALIZATION; ENZYME STABILITY; FEMALE; FIBROBLAST; GENE; GENE EXPRESSION; GENE IDENTIFICATION; HEXDC GENE; HUMAN; MALE; MOLECULAR PATHOLOGY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; STEADY STATE; SYNOVIAL FLUID; SYNOVIUM;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BETA-N-ACETYLHEXOSAMINIDASES; CELL LINE; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MIDDLE AGED; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

EID: 84872743597     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.10.012     Document Type: Article

References (29)

1. Okada S., O'Brien J.S. Tay-Sachs disease: generalized absence of a beta-d-N-acetylhexosaminidase component. Science 1969, 165(894):698-700.
2. Suzuki Y., Koizumi Y., Togari H., Ogawa Y. Sandhoff disease: diagnosis of heterozygous carriers by serum hexosaminidase assay. Clin Chim Acta 1973, 48(2):153-158.
3. Mark B.L., Mahuran D.J., Cherney M.M., Zhao D., Knapp S., James M.N. Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease. J Mol Biol 2003, 327(5):1093-1109.
4. Lemieux M.J., Mark B.L., Cherney M.M., Withers S.G., Mahuran D.J., James M.N. Crystallographic structure of human beta-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis. J Mol Biol 2006, 359(4):913-929.
5. Korneluk R.G., Mahuran D.J., Neote K., Klavins M.H., O'Dowd B.F., Tropak M., et al. Isolation of cDNA clones coding for the alpha-subunit of human beta-hexosaminidase. Extensive homology between the alpha- and beta-subunits and studies on Tay-Sachs disease. J Biol Chem 1986, 261:8407-8413.
6. Zwierz K., Zalewska A., Zoch-Zwierz A. Isoenzymes of N-acetyl-beta-hexosaminidase. Acta Biochim Pol 1999, 46(3):739-751.
7. Slámová K., Bojarová P., Petrásková L., Kren V. β-N-acetylhexosaminidase: what's in a name?. Biotechnol Adv 2010, 28(6):682-693.
8. Popko J., Marciniak J., Ilendo E., Knas M., Guszczyn T., Stasiak-Barmuta A., et al. Profile of exoglycosidases in synovial cell cultures derived from human synovial membrane. Cell Biochem Biophys 2008, 51(2-3):89-95.
9. Ortutay Z., Polgar A., Gomor B., Geher P., Lakatos T., Glant T.T., et al. Synovial fluid exoglycosidases are predictors of rheumatoid arthritis and are effective in cartilage glycosaminoglycan depletion. Arthritis Rheum 2003, 48:2163-2172.
10. Popko J., Marciniak J., Zalewska A., Górska A., Zwierz K., Sierakowski S., et al. Activity of N-acetyl-beta-hexosaminidase and its isoenzymes in serum and synovial fluid from patients with different arthropathies. Clin Exp Rheumatol 2006, 24(6):690-693.
11. Pancewicz S., Popko J., Rutkowski R., KnaŚ M., Grygorczuk S., Guszczyn T., et al. Activity of lysosomal exoglycosidases in serum and synovial fluid in patients with chronic Lyme and rheumatoid arthritis. Scand J Infect Dis 2009, 41(8):584-589.
12. Pásztói M., Nagy G., Géher P., Lakatos T., Tóth K., Wellinger K., et al. Gene expression and activity of cartilage degrading glycosidases in human rheumatoid arthritis and osteoarthritis synovial fibroblasts. Arthritis Res Ther 2009, 11(3):R68.
13. Gutternigg M., Rendić D., Voglauer R., Iskratsch T., Wilson I.B. Mammalian cells contain a second nucleocytoplasmic hexosaminidase. Biochem J 2009, 419(1):83-90.
14. György B., Szabó T.G., Pásztói M., Pál Z., Misják P., Aradi B., et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 2011, 68(16):2667-2688.
15. Valadi H., Ekström K., Bossios A., Sjöstrand M., Lee J.J., Lötvall J. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9(6):654-659.
16. Giusti I., D'Ascenzo S., Millimaggi D., Taraboletti G., Carta G., Franceschini N., et al. B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles. Neoplasia 2008, 10(5):481-488.
17. Théry C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009, 9(8):581-593.
18. Pap E., Pállinger E., Pásztói M., Falus A. Highlights of a new type of intercellular communication: microvesicle-based information transfer. Inflamm Res 2009, 58(1):1-8.
19. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
20. Altman R., Alarcon G., Appelrouth D., Bloch D., Borenstein D., Brandt K., et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991, 34:505-514.
21. Neidhart M., Gay R.E., Gay S. Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2000, 43:1719-1728.
22. György B., Módos K., Pállinger E., Pálóczi K., Pásztói M., Misják P., et al. Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. Blood 2011, 117(4):e39-e48.
23. Lefèvre S., Knedla A., Tennie C., Kampmann A., Wunrau C., Dinser R., et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 2009, 15(12):1414-1420.
24. Niedermeier M., Pap T., Korb A. Therapeutic opportunities in fibroblasts in inflammatory arthritis. Best Pract Res Clin Rheumatol 2010, 24(4):527-540.
25. Neumann E., Lefèvre S., Zimmermann B., Gay S., Müller-Ladner U. Rheumatoid arthritis progression mediated by activated synovial fibroblasts. Trends Mol Med 2010, 16(10):458-468.
26. Pap T., Meinecke I., Müller-Ladner U., Gay S. Are fibroblasts involved in joint destruction?. Ann Rheum Dis 2005, 64(Suppl. 4):iv52-iv54.
27. Szajda S.D., Waszkiewicz N., Chojnowska S., Zwierz K. Carbohydrate markers of pancreatic cancer. Biochem Soc Trans 2011, 39(1):340-343.
28. Choromańska B., Luto M., Szajda S.D., Waszkiewicz N., Kepka A., Janica J., et al. Activity of N-acetyl-β-hexosaminidase and its isoenzymes A and B in cancer. Postepy Hig Med Dosw 2011, 65:752-758.
29. Olszewska E., Borzym-Kluczyk M., Rzewnicki I., Rutkowska J., Knas M., et al. Hexosaminidase as a new potential marker for larynx cancer. Clin Biochem 2009, 42(10-11):1187-1189.